ARTICLE | Regulation
Califf, biopharma industry leaders support accelerated approval reforms
Califf, GSK’s Barron, BIO’s McMurry-Heath say centralized data collection is needed
January 12, 2022 1:49 AM UTC
Rob Califf, President Joe Biden’s nominee for FDA commissioner, has publicly endorsed the accelerated approval pathway, called for redoubling efforts to confirm clinical efficacy, and backed ...